SEARCH

SEARCH BY CITATION

References

  • 1
    Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13:267276.
  • 2
    Tilg H, Wilmer A, Vogl W, Herold M, Nolchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103:264274.
  • 3
    Lee FY, Lu RH, Tsai YT, Lin HC, Hou MC, Li CP, Liao TM, et al. Plasma interleukin-6 levels in patients with cirrhosis. Scand J Gastroenterol 1996; 31:500505.
  • 4
    Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, Cadelina G, et al. Interleukin-6, nitric oxide, and the clinical and haemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol 1999; 94:169177.
    Direct Link:
  • 5
    von Baehr V, Docke W-D, Plauth M, Liebenthal C, Kupferling S, Lochs H, Baumgarten R, et al. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 2000; 47:281287.
  • 6
    Andus T, Bauer J, Gerok K. Effects of cytokines on the liver. Hepatology 1991; 13:364375.
  • 7
    Enomoto N, Ikejima K, Bradford BU, Rivera CA, Kono H, Goto M, Yamashina S, et al. Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury. J Gastroenterol Hepatol 2000; 15(Suppl):D20D25.
  • 8
    Neuman M, Anhulo P, Malkiewicz I, Jorgensen R, Shear N, Dickson ER, Haber J, et al. Tumor necrosis factor-α and transforming growth factor-β reflect severity of liver damage in primary biliary cirrhosis. J Gastroenterol Hepatol 2002; 17:196202.
  • 9
    Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG. Antibodies to tumor necrosis factor-α attenuate hepatic necrosis and inflammation due to chronic exposure to ethanol in the rat. Hepatology 1997; 26:15301537.
  • 10
    Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG. Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice. Gastroenterology 1999; 117:942952.
  • 11
    French SW. Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J Biomed Sci 2001; 8:2027.
  • 12
    Nanji AA, Khettry U, Sadrzadeh SM, Yamanaka T. Severity of liver injury in experimental alcoholic liver disease. Am J Pathol 1993; 142:367373.
  • 13
    Rivera CA, Bradford BU, Seabra V, Thurman RG. Role of endotoxin in the hypermetabolic state following acute ethanol exposure. Am J Physiol 1998; 275:G1252G1258.
  • 14
    Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991; 12:162169.
  • 15
    Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, Hsu WC, et al. Entotoxaemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 1995; 22:165172.
  • 16
    Chan CC, Hwang SJ, Lee FY, Wang SS, Chang FY, Li CP, Chu CJ. Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol 1997; 32:942946.
  • 17
    Hanck C, Manigold T, Bocker U, Kurimoto M, Kolbel CB, Singer MV, Rossol S. Gene expression of interleukin 18 in unstimulated peripheral blood mononuclear cells of patients with alcoholic cirrhosis. Gut 2001; 49:106111.
  • 18
    Schafer C, Schips I, Landig J, Bode JC, Bode C. Tumor-necrosis factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease. Z Gastroenterol 1995; 33:503508.
  • 19
    Deviere J, Content J, Denys C, Vandenbussche P, LeMoine O, Schandene L, Vaerman JP, et al. Immunoglobulin A and interleukin 6 form a positive secretory feedback loop: a study of normal subjects and alcoholic cirrhotics. Gastroenterology 1992; 103:12961301.
  • 20
    Tilg H, Vogel W, Wiedermann CJ, Shapiro L, Herold M, Judmaier G, Dinabello CA, et al. Circulating interleukin 1 and tumor necrosis factor antagonists in liver disease. Hepatology 1993; 18:11321138.
  • 21
    Medzhitov R, Janeway C. Innate imunity. N Engl J Med 2000; 343:338344.
  • 22
    Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163:15.
  • 23
    Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675680.
  • 24
    Floch MH, Katz J, Conn HO. Qualitative and quantitative relationships of the fecal flora in cirrhotic patients with portal systemic encephalopathy and following portacaval anastomosis. Gastroenterology 1975; 59:7075.
  • 25
    Pardo A, Bartoli R, Lorenzo-Zuniga V, Planas R, Vinado B, Riba J, Cabre E, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation. Hepatology 2000; 31:858863.
  • 26
    Bauer TM, Steinbruckner B, Brinkmann FE, Ditzen AK, Schwacha H, Aponte JJ, Pelz K, et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol 2001; 96:29622967.
    Direct Link:
  • 27
    Tsuneyama K, Harada K, Kono N, Hiramatsu K, Zen Y, Sudo Y, Gershwin ME, et al. Scavenger cells with Gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis. J Hepatol 2001; 35:156163.
  • 28
    Kruszewska D, Lan J, Lorca G, Yanagisawa N, Marklinder I, Ljungh A. Selection of lactic acid bacteria as probiotic strains by in vitro tests. Microecol Ther (in press).
  • 29
    Johansson M-L, Molin G, Jeppsson B, Nobaek S, Ahrne S, Bengmark S. Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl Environ Microbiol 1993; 59:1520.
  • 30
    Herias MV, Hessle C, Telemo E, Midtvedt T, Hanson LA, Wold AE. Immunomodulatory effects of Lactobacillus plantarum colonizing the intestine of gnotobiotic rats. Clin Exp Immunol 1999; 116:283290.
  • 31
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646649.
  • 32
    van Leeuwen PA, Hong RW, Rounds JD, Rodrick ML, Wilmore D. Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin. Surgery 1991; 110:169174.
  • 33
    Manrekar P, Catalano D, Szabo G. Alcohol-induced regulation of nuclear regulatory factor-kappa beta in human monocytes. Alcohol Clin Exp Res 1997; 21:12261231.
  • 34
    Enomoto N, Ikejima K, Bradford B, Rivera C, Kono H, Brenner DA, Thurman RG. Alcohol causes both tolerance and sensitisation of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology 1998; 115:443451.
  • 35
    Bigatello LM, Broitman SA, Fattori L, Paoli MD, Pontello M, Bevilacqua G, Nespoli A, et al. Endotoxaemia, encephalopathy and mortality in cirrhotic patients. Am J Gastroenterol 1987; 82:1115.
  • 36
    Diez-Ruiz A, Tilz GP, Gutierrez-Gea F, Gil-Extremera B, Murr C, Wachter H, Fuchs D, et al. Neopterin and soluble tumor necrosis factor receptor type 1 in alcoholic cirrhosis. Hepatology 1995; 21:976978.
  • 37
    Knolle PA, Germann T, Treichel U, Uhrig A, Schmitt E, Hegenbarth S, Lohse AW, et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol 1998; 162:14011407.
  • 38
    Lumsden AD, Kuner MH. Endotoxin levels measured by chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988; 8:232236.
  • 39
    Ziegler-Heitbrock HWL. Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 1995; 45:1326.
  • 40
    Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88:17471754.
  • 41
    Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW. Downregulation of proinflammatory cytokine release in whole blood from septic shock patients. Blood 1995; 85:13411347.
  • 42
    de Werra I, Zanetti G, Jaccard C, Chiolero R, Schaller M-D, Yersin B, Glauser MP, et al. CD14 expression on monocytes and TNFa production in patients with septic shock, cardiogenic shock or bacterial pneumonia. Swiss Med Wkly 2001; 131:3540.
  • 43
    Perez-Paramo M, Munoz J, Albillos A, Freile I, Portero F, Santos M, Ortiz-Berrocal J, et al. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000; 31:4348.
  • 44
    Guarner C, Runyon BA, Young S, Heck M, Sheikh MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26:13721378.